Latanoprost

Facet patent anti-GPR64 (anti-GPR64) is a monoclonal antibody (mAb) against G protein-coupled receptor 64 isoform 4 (anti-GPR64) with potential anti-tumour activity.

PiSmart Screen Protector

32-000509-0000 EYESALINE 1-GALCONCENTRATE

32-000502-0000 EYESALINE 1-GALSOLUTION

G5010 UNMTD EYE/FACE/BODY SPRAY

General description Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards Application

Immunogen Synthetic peptide directed towards the middle region of human LATS1 Sequence Synthetic peptide located within the following region: IPPQAKLSPEASDLIIKLCRGPEDRLGKNGADEIKAHPFFKTIDFSSDLR Physical form Purified antibody supplied in 1x

Biochem/physiol Actions Eliglustat is a potent and selctive glucosylceramide synthase inhibitor approved for treatment of type 1 Gaucher disease.

Biochem/physiol Actions Eliglustat is a potent and selctive glucosylceramide synthase inhibitor approved for treatment of type 1 Gaucher disease.

Biochem/physiol Actions Losmapimod is a potent and selective inhibitor of the p38 mitogen-activated protein kinases (MAPK) family. In SHR-SP rats losmapimod improves survival, endothelial-dependent and -independent vascular relaxation.

Biochem/physiol Actions Losmapimod is a potent and selective inhibitor of the p38 mitogen-activated protein kinases (MAPK) family. In SHR-SP rats losmapimod improves survival, endothelial-dependent and -independent vascular relaxation.

General description This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the